We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Heron Therapeutics Inc. said that its late anesthetics for the treatment of Bunonnactomy and hernia repair hit all major and key secondary endpoints in two phase III trials